CARCINOMA, PANCREATIC DUCTAL

Clinical trials for CARCINOMA, PANCREATIC DUCTAL explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear

Sign up with your email to follow new studies for CARCINOMA, PANCREATIC DUCTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 2

Engineered immune cells take on pancreatic cancer in first human trial

Disease control Not yet recruiting

This early-phase trial tests a new treatment called CD318-CAR-T cells for people with advanced pancreatic cancer that has worsened after standard therapy. The therapy uses a patient's own immune cells, which are modified in a lab to recognize and attack cancer cells. The study ai…

Matched conditions: CARCINOMA, PANCREATIC DUCTAL

Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control

Last updated Jun 26, 2026 12:34 UTC

CARCINOMA, PANCREATIC DUCTAL

Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear

Engineered immune cells take on pancreatic cancer in first human trial